These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 24300307)

  • 1. Cost-effectiveness analysis at 2 years of surgical treatment of benign prostatic hyperplasia by photoselective vaporization of the prostate with GreenLight-Photo vaporization 120 W versus transurethral resection of the prostate.
    Benejam-Gual JM; Sanz-Granda A; García-Miralles Grávalos R; Severa-Ruíz de Velasco A; Pons-Viver J
    Actas Urol Esp; 2014 May; 38(4):238-43. PubMed ID: 24300307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter study on costs associated with two surgical procedures: GreenLight XPS 180 W versus the gold standard transurethral resection of the prostate.
    Benejam-Gual JM; Sanz-Granda A; Budía A; Extramiana J; Capitán C
    Actas Urol Esp; 2014; 38(6):373-7. PubMed ID: 24332528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Photoselective laser vaporization prostatectomy versus transurethral prostate resection: a cost analysis.
    Goh AC; Gonzalez RR
    J Urol; 2010 Apr; 183(4):1469-73. PubMed ID: 20172555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Holmium:YAG transurethral incision versus laser photoselective vaporization for benign prostatic hyperplasia in a small prostate.
    Elshal AM; Elkoushy MA; Elmansy HM; Sampalis J; Elhilali MM
    J Urol; 2014 Jan; 191(1):148-54. PubMed ID: 23845460
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GreenLight 180W XPS photovaporization of the prostate: how I do it.
    Zorn KC; Liberman D
    Can J Urol; 2011 Oct; 18(5):5918-26. PubMed ID: 22018158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia.
    Stovsky MD; Griffiths RI; Duff SB
    J Urol; 2006 Oct; 176(4 Pt 1):1500-6. PubMed ID: 16952668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Photovaporization of the prostate with GreenLight™ laser 180 W XPS versus transurethral resection of the prostate with monopolar energy for the treatment of benign prostatic enlargement: a cost-utility analysis from a healthcare perspective.
    Caicedo JI; Taborda A; Robledo D; Bravo-Balado A; Domínguez C; Trujillo CG; Cataño JG; Campos Hernández J; Londoño Trujillo D; Plata M
    World J Urol; 2019 May; 37(5):861-866. PubMed ID: 30116964
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cost analysis of GreenLight photoselective vaporization of the prostate versus standard transurethral resection of the prostate: Benefit of ambulatory care].
    Richard C; Robert G; Pradère B; Wilisch J; Doizi S; Le Calvez S; Negra ED;
    Prog Urol; 2021 Apr; 31(5):275-281. PubMed ID: 33461866
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A European multicenter randomized noninferiority trial comparing 180 W GreenLight XPS laser vaporization and transurethral resection of the prostate for the treatment of benign prostatic obstruction: 12-month results of the GOLIATH study.
    Bachmann A; Tubaro A; Barber N; d'Ancona F; Muir G; Witzsch U; Grimm MO; Benejam J; Stolzenburg JU; Riddick A; Pahernik S; Roelink H; Ameye F; Saussine C; Bruyère F; Loidl W; Larner T; Gogoi NK; Hindley R; Muschter R; Thorpe A; Shrotri N; Graham S; Hamann M; Miller K; Schostak M; Capitán C; Knispel H; Thomas JA
    J Urol; 2015 Feb; 193(2):570-8. PubMed ID: 25219699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for treatment of benign prostatic hyperplasia: a randomized clinical trial with midterm follow-up.
    Al-Ansari A; Younes N; Sampige VP; Al-Rumaihi K; Ghafouri A; Gul T; Shokeir AA
    Eur Urol; 2010 Sep; 58(3):349-55. PubMed ID: 20605316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thulium laser enucleation (ThuLEP) versus transurethral resection of the prostate in saline (TURis): A randomized prospective trial to compare intra and early postoperative outcomes.
    Bozzini G; Seveso M; Melegari S; de Francesco O; Buffi NM; Guazzoni G; Provenzano M; Mandressi A; Taverna G
    Actas Urol Esp; 2017 Jun; 41(5):309-315. PubMed ID: 28062085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GreenLight HPS 120-W laser vaporization versus transurethral resection of the prostate for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia: a randomized clinical trial with 2-year follow-up.
    Capitán C; Blázquez C; Martin MD; Hernández V; de la Peña E; Llorente C
    Eur Urol; 2011 Oct; 60(4):734-9. PubMed ID: 21658839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cost-minimisation analysis comparing photoselective vaporisation (PVP) and transurethral resection of the prostate (TURP) for the management of symptomatic benign prostatic hyperplasia (BPH) in Queensland, Australia.
    Whitty JA; Crosland P; Hewson K; Narula R; Nathan TR; Campbell PA; Keller A; Scuffham PA
    BJU Int; 2014 Mar; 113 Suppl 2():21-8. PubMed ID: 23574626
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Greenlight laser in benign prostatic hyperplasia: turning green into gold.
    Alivizatos G; Skolarikos A
    Curr Opin Urol; 2008 Jan; 18(1):46-9. PubMed ID: 18090489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laser transurethral resection of the prostate: Safety study of a novel system of photoselective vaporization with high power diode laser in prostates larger than 80mL.
    Andrés G; Arance I; Gimbernat H; Redondo C; García-Tello A; Angulo JC
    Actas Urol Esp; 2015; 39(6):375-82. PubMed ID: 25745792
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GreenLight HPS™ 120-W laser vaporization vs transurethral resection of the prostate (<60 mL): a 2-year randomized double-blind prospective urodynamic investigation.
    Pereira-Correia JA; de Moraes Sousa KD; Santos JB; de Morais Perpétuo D; Lopes-da-Silva LF; Krambeck RL; Muller VJ; Vaz FP
    BJU Int; 2012 Oct; 110(8):1184-9. PubMed ID: 22257240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of holmium laser enucleation of the prostate (HoLEP) for recurrent/residual benign prostatic hyperplasia (BPH).
    Elshal AM; Elmansy HM; Elhilali MM
    BJU Int; 2012 Dec; 110(11 Pt C):E845-50. PubMed ID: 22702908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacotherapy vs surgery as initial therapy for patients with moderate-to-severe benign prostate hyperplasia: a cost-effectiveness analysis.
    Erman A; Masucci L; Krahn MD; Elterman DS
    BJU Int; 2018 Nov; 122(5):879-888. PubMed ID: 30113127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of photoselective vaporization of the prostate using the 80-W potassium-titanyl-phosphate laser vs transurethral prostatectomy, with a 1-year follow-up.
    Bouchier-Hayes DM; Van Appledorn S; Bugeja P; Crowe H; Challacombe B; Costello AJ
    BJU Int; 2010 Apr; 105(7):964-9. PubMed ID: 19912196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Photoselective vaporization for benign prostatic hyperplasia.
    Murtagh J; Foerster V
    Issues Emerg Health Technol; 2006 Dec; (95):1-4. PubMed ID: 17176529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.